Results 41 to 50 of about 1,674,400 (206)

PREDICTION OF ATRIAL FIBRILLATION RECURRENCE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION SUFFERING FROM OBSTRUCTIVE SLEEP APNOEA/HYPOPNOEA SYNDROME

Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2019
Background. Untreated obstructive sleep apnoea-hypopnoea syndrome (OSAHS) in atrial fibrillation (AF) patients influences the efficacy of antiarrhythmic drug therapy and reduces electrical cardioversion and catheter ablation success rates.
Balabanovich T. I., Shyshko V. I.
doaj   +1 more source

Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group. [PDF]

, 2020
AIMS: As health systems around the world increasingly look to measure and improve the value of care that they provide to patients, being able to measure the outcomes that matter most to patients is vital.
Arbelo, E, Banerjee, A, Bollmann, A, Caffrey-Armstrong, B, Camm, AJ, Cehic, DA, Collins, M, Corbalan, R, Dandamudi, G, Das-Gupta, Z, Dorairaj, P, Fay, M, Goto, S, Granger, CB, Gyorgy, B, Healey, JS, Hendriks, JM, Hills, MT, Hobbs, FDR, Huisman, MV, Jobi-Odeneye, AO, Koplan, KE, Lane, DA, Lewis, WR, Lobban, T, McLeod, CJ, Moseley, S, Seligman, WH, Steinberg, BA, Timmis, A, Van Gelder, IC, Yutao, G   +31 more
core   +4 more sources

External cardioversion of atrial fibrillation and flutter in patients with cardiac implantable electrical devices

Pacing and clinical electrophysiology : PACE, 2022
Atrial fibrillation and flutter are often treated with external electrical cardioversion (ECV) in patients with potentially electrically sensitive cardiovascular implantable electronic devices (CIED).
A. F. Elgaard, P. Dinesen, S. Riahi, J. Hansen, S. Lundbye-Christensen, A. Thøgersen, J. Larsen   +6 more
semanticscholar   +1 more source

Impact of atrial fibrillation on the cardiovascular system through a lumped-parameter approach [PDF]

, 2014
Atrial fibrillation (AF) is the most common arrhythmia affecting millions of people in the Western countries and, due to the widespread impact on the population and its medical relevance, is largely investigated in both clinical and bioengineering ...
Camporeale, Carlo, Guala, Andrea, Ridolfi, Luca, Scarsoglio, Stefania   +3 more
core   +2 more sources

Vernakalant and electrical cardioversion for AF – Safe and effective

International Journal of Cardiology: Heart & Vasculature, 2019
Aims: Rapid restoration of sinus rhythm is an integral part of the management of recent-onset atrial fibrillation. We aimed to assess safety and efficacy of vernakalant, a multi-channel blocking agent, in combination with external electrical ...
Alexander Simon, Jan Niederdoeckl, Karin Janata, Alexander Oskar Spiel, Nikola Schuetz, Sebastian Schnaubelt, Harald Herkner, Filippo Cacioppo, Anton Norbert Laggner, Hans Domanovits   +9 more
doaj   +1 more source

Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation [PDF]

, 2018
Background: Based on its pharmacokinetic profile and electrophysiological effects in healthy horses, sotalol potentially could be used as a long-term PO antiarrhythmic drug in horses.
Anderson, Barrell, Brakel, Broux, Broux, Campbell, Clercq, Clercq, Clercq, Decloedt, Decloedt, Decloedt, Deem, Dufourni, Haugaard, Heliczer, January, Kerin, Lafuente-Lafuente, Loon, Mansour, McGurrin, Meurs, Milan, Pedersen, Rasmussen, Reef, Reef, Verheyen, Wang, Wijffels, Wijffels   +31 more
core   +2 more sources

The presence of fragmented QRS may predict the recurrence of nonvalvular atrial fibrillation after successful electrical cardioversion

Annals of Noninvasive Electrocardiology, 2020
Atrial fibrillation (AF), the most common cardiac rhythm disorder, affects approximately 2% of the general population and is associated with increased risk of stroke and mortality as well as reduced exercise capacity and quality of life.
Hayati Eren, Ü. Kaya, L. Öcal, Ahmet Şenbaş, M. Kalçık   +4 more
semanticscholar   +1 more source

Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation

Medicina, 2022
Atrial fibrillation (AF) is the most frequent chronic arrhythmia worldwide, and it is associated with significant morbidity and mortality, making it a considerable burden both to patients and the healthcare system.
Marco Valerio Mariani, Nicola Pierucci, Agostino Piro, Sara Trivigno, Cristina Chimenti, Gioacchino Galardo, Fabio Miraldi, Carmine Dario Vizza   +7 more
doaj   +1 more source

The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. [PDF]

, 2017
The ENSURE-AF study (NCT 02072434) of anticoagulation for electrical cardioversion in nonvalvular atrial fibrillation (NVAF) showed comparable low rates of bleeding and thromboembolism between the edoxaban and the enoxaparin-warfarin treatment arms. This
Al-Saady, N, Banach, M, Ezekowitz, MD, Goette, A, Lip, GYH   +4 more
core   +2 more sources

Termination of Idiopathic Sustained Monomorphic Ventricular Tachycardia by Synchronized Electrical Cardioversion during Pregnancy [PDF]

Acute and Critical Care, 2018
The most common cardiac complications detected during pregnancy are an arrhythmia. However, idiopathic continuous monomorphic ventricular tachycardia (VT) during pregnancy is unusual.
Sungmin Lee
doaj   +1 more source